← back to search

Zhongyang Liu

Fudan University · CN
Area of research
Molecular Biology · Computational Theory and Mathematics
Research interest
Research interests include Glioma, Drug delivery, Nanocarriers, Chemistry, Blood–brain barrier, and Cancer research.
h-index
citations
2,229
works
13
NIH funding
primary concept
email

Recent publications

scCT-DB, an omnibus for cancer patient-derived paired pre- and post-treatment single-cell transcriptomes to reveal drug perturbation and drug resistance mechanisms
Nucleic Acids Research 2025cited by 1position: lastdoi
Exploring the DNA-binding and anticancer potential of polypyridyl ruthenium(II) complexes
Journal of Molecular Structure 2024cited by 10position: middledoi
BATMAN-TCM: a Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine
Scientific Reports 2016cited by 832position: firstdoi
Caveolin-1 contributes to realgar nanoparticle therapy in human chronic myelogenous leukemia K562 cells
International Journal of Nanomedicine 2016cited by 28position: middledoi
Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration
Biomaterials 2013cited by 209position: firstdoi
Glioma therapy using tumor homing and penetrating peptide-functionalized PEG–PLA nanoparticles loaded with paclitaxel
Biomaterials 2013cited by 165position: middledoi
B6 Peptide-Modified PEG-PLA Nanoparticles for Enhanced Brain Delivery of Neuroprotective Peptide
Bioconjugate Chemistry 2013cited by 160position: firstdoi
The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells
Biomaterials 2013cited by 135position: middledoi
Co-administration of Dual-Targeting Nanoparticles with Penetration Enhancement Peptide for Antiglioblastoma Therapy
Molecular Pharmaceutics 2013cited by 83position: middledoi
F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery
Biomaterials 2012cited by 189position: middledoi
PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy
Biomaterials 2012cited by 181position: middledoi
Penetratin-functionalized PEG–PLA nanoparticles for brain drug delivery
International Journal of Pharmaceutics 2012cited by 159position: middledoi
Preparation and characterization of paclitaxel-loaded DSPE-PEG-liquid crystalline nanoparticles (LCNPs) for improved bioavailability
International Journal of Pharmaceutics 2012cited by 77position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Quanyin Hu · University of Wisconsin–Madison9 papers (2012–2013)Guangzhi Gu · Fudan University9 papers (2012–2013)Xiaoling Gao · Guangzhou University of Chinese Medicine9 papers (2012–2013) · 9 papers (2012–2013)Ting Kang · Fudan University7 papers (2012–2013)Zhiqing Pang · Peking University7 papers (2012–2013)Xinguo Jiang · Fudan University7 papers (2012–2013)Mengyin Jiang · Fudan University6 papers (2012–2013)Deyu Miao · Fudan University6 papers (2012–2013)Hongzhuan Chen · Shanghai University of Traditional Chinese Medicine5 papers (2012–2013)Lei Yao · Nantong University5 papers (2012–2013)Yifan Tu · Fudan University5 papers (2012–2013)Huimin Xia · Honghu Hospital of Traditional Chinese Medicine4 papers (2012–2012)Jun Chen · Jimei University4 papers (2012–2013)Lei Yao · Fujian Medical University3 papers (2012–2013)Hongzhan Chen · Ningbo University2 papers (2012–2012)Dong Li · Beijing University of Chinese Medicine2 papers (2016–2025)Yifan Tu · Fudan University2 papers (2012–2013)Dan Shi · Nantong University1 papers (2016–2016)Lihong Diao · Beijing Proteome Research Center1 papers (2016–2016)